Trials / Unknown
UnknownNCT04628403
Effects of Clinical Interventions for the Management of Late Start
Effects of Clinical Interventions for the Management of Late Start Muscular Pain (Doms) in the Post-exercise Recovery Process
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- São Paulo State University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Introduction: Late-onset muscle pain (DOMS) is characterized by a type of temporary muscle damage, common after high-intensity exercise. In addition to pain, DOMS clinically generates muscle stiffness, reduced joint range of motion, muscle weakness and reduced peak torque. In this regard, in order to accelerate the recovery of body systems and treat symptoms of DOMS, the management of different types of interventions has been observed, supporting the clinical practice, based on evidence. Objectives: To investigate the effect of different types of clinical interventions for the treatment of DOMS. Material and methods: For the clinical trial, 50 ultramarathon and rowing athletes of both sexes, aged between 18 and 60 years old, will be recruited randomly into four possible groups: control (CG), shock waves (G1) , massage (G2) and laser therapy (G3). The evaluation moments will be as follows: minutes before exercise (M1); immediately after exercise (M2); immediately after applying the recovery technique (M3); and 24 hours after exercise (M4) and the evaluated outcomes will be: pain, psychological aspects, functional test and blood markers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | massage | clinical interventions, of mechanophysiological origin for the treatment of symptoms corresponding to DOMS, after exercise |
| DEVICE | lasertherapy | lasertherapy |
| DEVICE | shock waves | shock waves |
Timeline
- Start date
- 2020-11-20
- Primary completion
- 2021-01-29
- Completion
- 2021-03-20
- First posted
- 2020-11-13
- Last updated
- 2020-11-13
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT04628403. Inclusion in this directory is not an endorsement.